Abstract
In a controlled clinical study ("clinical trial") to compare 2 or more treatments for a disease, an objective method of allocating patients to treatment groups is needed. Various existing methods of allocation are described, including those which take account of patients' pre-treatment characteristics.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
White, S., Freedman, L. Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer 37, 849–857 (1978). https://doi.org/10.1038/bjc.1978.124
Issue Date:
DOI: https://doi.org/10.1038/bjc.1978.124
This article is cited by
-
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41
Breast Cancer Research and Treatment (2023)
-
Stepped care management of insomnia co-occurring with sleep apnea: the AIR study protocol
Trials (2022)
-
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)
Breast Cancer Research and Treatment (2022)
-
E-Freeze - a randomised controlled trial evaluating the clinical and cost effectiveness of a policy of freezing embryos followed by thawed frozen embryo transfer compared with a policy of fresh embryo transfer, in women undergoing in vitro fertilisation: a statistical analysis plan
Trials (2020)
-
Investigating the relationship between predictability and imbalance in minimisation: a simulation study
Trials (2013)
